Aurora Announces Manufacturing Agreement with The Valens Company
New Seasonal Offerings Slated for November Release
EDMONTON, AB, Oct. 28, 2021 /PRNewswire/ – Aurora Cannabis Inc. (the “Company” or “Aurora”) (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, today announced a manufacturing agreement with The Valens Company Inc. (“The Valens Company” or “Valens”) a leading manufacturer of cannabis products, to manufacture a new seasonal offering in the mint category.
Launching under Drift Turbo, the Company’s mainstream adult-use recreational brand, the new Canna Cane Mints are a two-piece hard peppermint candy containing 10mg THC (5mg THC per piece). This is the first product offering under the manufacturing arrangement, which is expected to expand in the coming months.
We know that Canadian cannabis consumers are looking for novelty and variety, and seasonal offerings are a key approach to strategically expanding our portfolio of adult-use products. Valens’ exceptional manufacturing capabilities complement our product line up this upcoming holiday season.
Miguel Martin, CEO, Aurora Cannabis
Our strategic relationship is designed to unlock efficiencies as we seek to bring innovation to market with speed and differentiation that connects with consumers.
The cannabis edibles will be manufactured using SōRSE™ by Valens emulsion technology, a patented, in-house emulsion technology that transforms cannabis oils into water-soluble forms to infuse foods, liquids and topicals without the taste or smell of cannabis.
This is an important milestone for the Canadian cannabis market as two of the largest companies in this sector come together. We have admired Aurora for their leadership and continuing to elevate and challenge industry standards.
Tyler Robson, Chief Executive Officer, Co-Founder and Chair of The Valens Company
Our companies share the same ethos when it comes to bringing the highest quality products to market and offering a premium experience to consumers.
Aurora’s upcoming holiday portfolio will also include a new 510 vape cartridge launching under the Company’s adult-use recreational brand, Daily Special. The new Cranberry Sauce 1g 510 Vape is a high-THC distillate vape and is infused with the classic sweet-tart flavour of festive cranberries. Both the Canna Cane Mints and Cranberry Sauce Vape are limited-time products and will be available for purchase in British Columbia and Alberta beginning in November. The Cranberry Sauce 1g 510 Vape will also be available for purchase in the Maritimes.
About Aurora:
Aurora is a global leader in the cannabis industry, serving both the medical and consumer markets. Headquartered in Edmonton, Alberta, Aurora is a pioneer in global cannabis dedicated to helping people improve their lives. The Company’s brand portfolio includes Aurora, Aurora Drift, San Rafael ’71, Daily Special, MedReleaf, CanniMed, Whistler, Reliva and KG7 CBD. Driven by science and innovation, and with a focus on high-quality cannabis products, Aurora’s brands continue to break through as industry leaders in the medical, performance, wellness and adult recreational markets wherever they are launched. Learn more at www.auroramj.com and follow us on Twitter and LinkedIn.
Aurora’s common shares trade on the TSX and NASDAQ under the symbol “ACB” and is a constituent of the S&P/TSX Composite Index.
About The Valens Company:
The Valens Company is a leading cannabis consumer products company, with significant expertise in manufacturing cannabinoid based products and a mission to bring the benefits of cannabis to the world. Valens provides proprietary cannabis processing services and best-in-class product development, manufacturing, and commercialization of cannabis consumer packaged goods. Valens’ high-quality products are formulated for the recreational, health and wellness, and medical consumer segments and are offered across all cannabis product categories, with a focus on quality and product innovation. Valens also manufactures, distributes, and sells a wide range of CBD products in the United States through its subsidiary Green Roads, and distributes medicinal cannabis products to international markets through its subsidiary Valens Australia. In partnership with brand houses, consumer packaged goods companies and licensed cannabis producers around the globe, Valens continues to grow its diverse product portfolio in alignment with evolving cannabis consumer preferences. Through Valens Labs, Valens is setting the standard in cannabis testing and research and development with Canada’s only ISO17025 accredited analytical services lab, named The Centre of Excellence in Plant-Based Science by partner and scientific world leader Thermo Fisher Scientific. Discover more on The Valens Company at http://www.thevalenscompany.com.
